A cost-effective approach to the use of selective serotonin reuptake inhibitors in a veterans affairs medical center

American Journal of Managed Care

Volumn 3, Issue 1, 1997, Pages 125-129

  Singletary, Tony ^a   North, Donald S ^a   Weiss, Malcolm ^a   Marman, Gerry ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; COST BENEFIT ANALYSIS; DEPRESSION; DRUG COST; ECONOMICS; HEALTH INSURANCE; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; COLORADO; COST-BENEFIT ANALYSIS; DEPRESSION; DRUG COSTS; HOSPITALS, VETERANS; HUMANS; MANAGED CARE PROGRAMS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 0030624814     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993;94(suppl 5A):2S-12S.
2. Leonard BE. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 1992;42(suppl 2):3-10.
3. Feighner JP, Gardner EA, Johnson JA, et al. Double blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry 1991;52:329-335.
4. Dunner DL, Cohn JB, Walshe T, et al. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry 1992;53(suppl 2):57-60.
5. Stark P, Hardison CD. A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985;45:53-58.
6. Apter JT, Birkett M. Fluoxetine treatment in depressed patients who failed treatment with sertraline. Presented at the 34th Annual Meeting of the American College of Neuropsychopharmacology; December 11-15, 1995; San Juan, Puerto Rico.
7. Donoghue JM. A comparison of prescribing patterns of selective serotonin reuptake inhibitors in the treatment of depression in primary care in the United Kingdom. J Seroton Res 1995;1:47-51.
8. Sclar DA, Robison LM, Skaer TL, et al. Antidepressant pharmacotherapy: Economic outcomes in a health maintenance organization. Clin Ther 1994;16:715-731.
9. Stock AJ, Kofoed L. Therapeutic interchange of fluoxetine and sertraline: Experience in the clinical setting. Am J Hosp Pharm 1994;51:2279-2281.
10. DeVane CL. Pharmacokinetics of the selective serotonin reuptake inhibitors. J Clin Psychiatry 1992;53(suppl 2):13-20.
11. Preskorn SH. Advances in antidepressant pharmacotherapy. Psychiatr Times 1995;12:37-42.
12. North DS, Marman GW. Therapeutic interchange of fluoxetine and sertraline (letter). Am J Health-Syst Pharm 1995; 52:424.
13. Cohn CK, Shrivastava R, Mendels J, et al. Double-blind multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990;51(12, suppl B):28-33.
14. Gregor KJ, Overhage JM, Coons SJ, McDonald RC. Selective serotonin reuptake inhibitor dose titration in the naturalistic setting. Clin Ther 1994;16:306-315.
15. Simon GE, VonKorff H, Heiligenstein JH, et al. Initial antidepressant choice in primary care: Effectiveness and cost of fluoxetine vs. tricyclic antidepressants. JAMA 1996;275:1897-1902.